Fractyl Health, Inc. Common Stock (GUTS)

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Fractyl Health, Inc. Common Stock (GUTS) is listed on Nasdaq, where it has traded since February 2, 2024.

Listed On
Nasdaq
Listed Since
February 2, 2024
Employees
73
Market Cap
$77M

About Fractyl Health, Inc. Common Stock

Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 73 institutions reported holding GUTS, with 70.8 million shares worth $56.2 million in aggregate. The largest reported holder was Nantahala Capital Management, with 11.3 million shares worth $9.0 million. Of the 5 largest holders listed below, 3 added shares and 2 reduced their positions during the quarter.

InstitutionSharesValueQuarter change
Nantahala Capital Management11,289,096$9MReduced 15.53%
Vanguard6,860,369$5MAdded 11%
Catalio Capital Management6,168,749$5MAdded 12.33%
Bank of America6,034,147$5MAdded 4727.74%
Pale Fire Capital5,003,237$4MReduced 15.5%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is GUTS?

Fractyl Health, Inc. Common Stock (GUTS) is listed on Nasdaq, where it has traded since February 2, 2024.

Who are the largest institutional holders of GUTS?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of GUTS were Nantahala Capital Management, Vanguard and Catalio Capital Management.

How many institutions own GUTS?

73 institutions reported a position in GUTS for the quarter ended June 30, 2026, worth $56.2 million in total.

Did institutions buy or sell GUTS last quarter?

Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for GUTS.

Every reported institutional holder, plus insider and congressional trades in GUTS, on SentiSense.